MicroDose Therapeutx to Present at the 30th Annual Cowen Healthcare Conference on Tuesday, March 9th
MONMOUTH JUNCTION, N.J. USA – March 3, 2010 — MicroDose Therapeutx Inc. today announced that it has been invited to give a corporate presentation at Cowen & Company, LLC’s 30th Annual Healthcare Conference being held at the Boston Marriot Copley Place, Boston, MA from Monday March 8th through Thursday, March 11th, 2010.
Anand V. Gumaste, PhD, MicroDose’s President and Chief Executive Officer, will provide an overview of the company on Tuesday, March 9th at 10:00a.m. Eastern Standard Time.
About MicroDose Therapeutx
MicroDose Therapeutx is a privately-held specialty pharmaceutical company dedicated to improving the quality of life for people suffering from serious diseases. The company focuses on developing proprietary products that address large unmet market opportunities, and on drug delivery platforms for the pulmonary, oral and transdermal delivery of medications. The company develops its products and technologies independently, as well as in partnership with leading pharmaceutical companies. MicroDose’s products and platforms currently target respiratory disease states such as asthma, COPD and RSV disease, as well as constipation and diabetes among others.
For more information on MicroDose Therapeutx, please visit www.mdtx.com or contact:
Scott Fleming, Senior V.P., Sales & Marketing at 732-355-2114 or sfleming@mdtx.com